Appropriate use criteria (AUC) for the use of amyloid and tau positron emission tomography (PET) have been issued by the ...
Access to the new Alzheimer's drugs is limited by strict eligibility criteria, long wait times, and a lack of infusion ...
New research suggests that Americans' risk for developing dementia over a lifetime may be higher than previously thought.
Since its approval in 2023, the Alzheimer's disease drug made by Biogen Inc. and Eisai has seen a lackluster launch. However, ...
Discover the link between REM sleep and Alzheimer's disease. Learn how delayed REM sleep may indicate elevated protein levels ...
Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...
Research indicates longer REM latency is associated with higher Alzheimer's biomarkers, pointing to its potential as an early ...
FirstHealth Moore Regional Hospital announces the availability of PET Amyvid brain scans, a cutting-edge diagnostic tool ...